Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: A multicenter, double-blind, placebo-controlled, dose-ranging study

Cardiovascular Drugs and Therapy

Volumn 11, Issue 5, 1997, Pages 637-643

  Hart, Wimpeter ^a   Holwerda, Nicolas J ^b  

^a NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE   (Netherlands)

^b CPRLab   (Netherlands)

Author keywords

Barnidipine; Calcium antagonists; Dose ranging study; Hypertension

Indexed keywords

CALCIUM ANTAGONIST; MEPIRODIPINE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; FLUSHING; HEADACHE; HEART PALPITATION; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SITTING; STANDING; VASODILATATION;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; EDEMA; FEMALE; FLUSHING; HEADACHE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE;

EID: 0031446572     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007778706354     Document Type: Article

References (16)

1. World Health Organization/International Society of Hypertension. 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993;11:905-918.
2. Satoh H. Pharmacology and therapeutic effects of mepirodipine. Cardiovasc Drug Rev 1991;9:340-356.
3. Kashiwabara T, Nakayama K, Yamada S, Tanaka Y. Long-lasting and potent Ca antagonistic actions of a novel dihydropyridine with two asymmetric centers (YM-09730-5) assessed in the porcine coronary artery. Jpn J Pharmacol 1987; (Suppl. 43):731.
4. Nakayama K, Kashiwabara S, Yamada S, et al. Assessment in pig coronary artery of long-lasting and potent calcium antagonist actions of the novel dihydropyridine derivative mepirodipine hydrochloride. Arzneimittelforschung 1989;39:50-55.
5. Bauer P. Multiple testing in clinical trials. Stat Med 1991;10:871-890.
6. D'Hont G, Meurant JP, Clement DL, et al. Long-term (2-year) isradipine data in the treatment of mild-to-moderate hypertension. J Cardiovasc Pharmacol 1992;19(Suppl. 3): S46-S48.
7. Nami R, Rizzini P, Buracchi P, Pavese G, Gennari C. Long-term antihypertensive treatment with lacidipine, a new long-acting calcium antagonist. J Cardiovasc Pharmacol 1991;18(Suppl. 11):S22-S25.
8. Tourkantonis A, Lasaridis A, Settas L. Clinical experience with long-term nitrendipine treatment in essential hypertension. J Cardiovasc Pharmacol 1984;6:S1090-S1095.
9. Mehta JL, Lopez LM, Vlachakis ND, et al. Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension. Am Heart J 1993;125:1704-1710.
10. Saragoça AM, Portela JE, Abreu P, et al. Regression of left ventricular hypertrophy in the short-term treatment of hypertension with isradipine. Am J Hypertens 1991;4:S188-S190.
11. Cruickshank JM, McAinsh J. Patient compliance on taking cardiovascular drug therapy. Acta Therap 1992;18:53-60.
12. Omvik P, Thaulow E, Herland OB, Eide I, Midha R, Turner RR. A double-blind, long-term, comparative study on quality of life, safety, and efficacy during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: A multicenter study. J Cardiovasc Pharmacol 1993;22(Suppl. A):S13-S19.
13. Frick MH, McGibney D, Tyler HM. A dose-response study of amlodipine in mild to moderate hypertension. J Intern Med 1989;225:101-105.
14. Ventura HO, Messerli FH, Oigman W, Dunn FG, Reisin E, Frohlich ED. Immediate hemodynamic effects of a new calcium channel blocking agent (nitrendipine) in essential hypertension. Am J Cardiol 1983;51:783-786.
15. Ferrari R, Cucchini F, Bolognesi R, et al. How do calcium antagonists differ in clinical practice? Cardiovasc Drugs Ther 1994;8:565-575.
16. Dougall HT, McLay J. A comparative review of the adverse effects of calcium antagonists. Drug Safety 1996;15:91-106.